Screening for ADHD Symptoms among Criminal Offenders: Exploring the Association with Clinical Features.

attention-deficit/hyperactivity disorder childhood trauma comorbid prison

Journal

Healthcare (Basel, Switzerland)
ISSN: 2227-9032
Titre abrégé: Healthcare (Basel)
Pays: Switzerland
ID NLM: 101666525

Informations de publication

Date de publication:
18 Jan 2022
Historique:
received: 25 11 2021
revised: 14 01 2022
accepted: 16 01 2022
entrez: 25 2 2022
pubmed: 26 2 2022
medline: 26 2 2022
Statut: epublish

Résumé

Attention-deficit/hyperactivity disorder (ADHD) is a disabling disorder. High rates of ADHD have been consistently reported among prisoners. The main objectives were (1) to estimate the prevalence of ADHD symptoms in a sample of male inmates and (2) to investigate the relationship between ADHD symptoms and socio-demographic/clinical features. According to the high prevalence of childhood trauma among inmates, we assessed whether exposition to childhood trauma can be related to the presence of ADHD symptoms. A total of 159 male prisoners admitted to Monza prison between January 2020 and June 2021 were included. Both Wender Utah ADHD rating scale and adult ADHD self-report scale were administered to assess ADHD symptoms. Moreover, inmates completed the childhood trauma questionnaire. Data were available for 108 inmates. Thirty-five prisoners (32.4%) were found on screening to meet the criteria for symptoms of ADHD. Cocaine use disorder, prescription of mood stabilizers and a history of emotional abuse significantly increased the likelihood of having clinically significant ADHD symptoms. Furthermore, patients who experienced physical neglect resulted in meeting the criteria for ADHD symptoms. ADHD symptoms are widespread among inmates and are associated with specific risk factors. Screening for ADHD should be done to provide appropriate intervention strategies.

Sections du résumé

BACKGROUND BACKGROUND
Attention-deficit/hyperactivity disorder (ADHD) is a disabling disorder. High rates of ADHD have been consistently reported among prisoners. The main objectives were (1) to estimate the prevalence of ADHD symptoms in a sample of male inmates and (2) to investigate the relationship between ADHD symptoms and socio-demographic/clinical features. According to the high prevalence of childhood trauma among inmates, we assessed whether exposition to childhood trauma can be related to the presence of ADHD symptoms.
METHODS METHODS
A total of 159 male prisoners admitted to Monza prison between January 2020 and June 2021 were included. Both Wender Utah ADHD rating scale and adult ADHD self-report scale were administered to assess ADHD symptoms. Moreover, inmates completed the childhood trauma questionnaire.
RESULTS RESULTS
Data were available for 108 inmates. Thirty-five prisoners (32.4%) were found on screening to meet the criteria for symptoms of ADHD. Cocaine use disorder, prescription of mood stabilizers and a history of emotional abuse significantly increased the likelihood of having clinically significant ADHD symptoms. Furthermore, patients who experienced physical neglect resulted in meeting the criteria for ADHD symptoms.
CONCLUSIONS CONCLUSIONS
ADHD symptoms are widespread among inmates and are associated with specific risk factors. Screening for ADHD should be done to provide appropriate intervention strategies.

Identifiants

pubmed: 35206795
pii: healthcare10020180
doi: 10.3390/healthcare10020180
pmc: PMC8872480
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

J Clin Psychiatry. 2008 Sep;69(9):1477-84
pubmed: 19193347
J Trauma Stress. 2012 Aug;25(4):384-92
pubmed: 22806701
J Affect Disord. 2018 Jan 15;226:85-91
pubmed: 28964997
Proc Natl Acad Sci U S A. 2001 Apr 24;98(9):5300-5
pubmed: 11320258
Psychol Med. 2005 Feb;35(2):245-56
pubmed: 15841682
Int J Environ Res Public Health. 2020 May 17;17(10):
pubmed: 32429586
Eur Addict Res. 2020;26(4-5):179-190
pubmed: 32615575
Drug Alcohol Depend. 2018 Jul 1;188:135-140
pubmed: 29775957
J Clin Psychiatry. 2000 Apr;61(4):244-51
pubmed: 10830144
Eur Arch Psychiatry Clin Neurosci. 2018 Jun;268(4):391-399
pubmed: 28612143
Hum Psychopharmacol. 2017 Sep;32(5):
pubmed: 28750478
Epidemiol Rev. 2008;30:133-54
pubmed: 18653727
BMC Psychiatry. 2018 Sep 4;18(1):281
pubmed: 30180832
Compr Psychiatry. 2001 Jul-Aug;42(4):326-36
pubmed: 11458308
J Am Acad Child Adolesc Psychiatry. 1997 Mar;36(3):340-8
pubmed: 9055514
J Clin Med. 2021 Apr 02;10(7):
pubmed: 33918432
Curr Drug Abuse Rev. 2015;8(2):119-33
pubmed: 26373850
J Pers Disord. 2007 Jun;21(3):243-61
pubmed: 17536938
J Psychiatr Res. 2011 Jun;45(6):742-7
pubmed: 21115183
Child Abuse Negl. 2018 Jul;81:274-285
pubmed: 29775871
J Subst Abuse Treat. 2020 Nov;118:108104
pubmed: 32972651
Ir J Psychol Med. 2018 Sep;35(3):193-201
pubmed: 30124183
Genes Brain Behav. 2014 Jul;13(6):543-9
pubmed: 24805005
Child Psychiatry Hum Dev. 2017 Oct;48(5):691-698
pubmed: 27734259
J Atten Disord. 2016 Oct;20(10):815-24
pubmed: 24284138
Int J Methods Psychiatr Res. 2007;16(2):52-65
pubmed: 17623385
Clin Nucl Med. 2014 Feb;39(2):e129-34
pubmed: 23856832
Eur Psychiatry. 2016 Jan;31:29-36
pubmed: 26657598
J Psychiatr Res. 2021 Nov;143:587-598
pubmed: 33199055
Am J Public Health. 2019 Mar;109(3):e1-e11
pubmed: 30676787
Psychol Med. 2015;45(12):2499-510
pubmed: 25857258
J Atten Disord. 2006 May;9(4):631-41
pubmed: 16648230
Health Expect. 2022 Feb;25(1):366-373
pubmed: 34856044
Psychol Med. 2015 Jan;45(2):247-58
pubmed: 25066071
J Trauma Stress. 2001 Oct;14(4):843-57
pubmed: 11776429
Curr Psychiatry Rep. 2019 Apr 29;21(6):41
pubmed: 31037396
BMC Psychiatry. 2010 Dec 22;10:112
pubmed: 21176203
BMC Psychiatry. 2014 May 07;14:133
pubmed: 24884622
Am J Psychiatry. 1993 Jun;150(6):885-90
pubmed: 8494063
Borderline Personal Disord Emot Dysregul. 2021 Feb 3;8(1):5
pubmed: 33536068
J Am Acad Psychiatry Law. 2009;37(1):45-9
pubmed: 19297632
Front Psychiatry. 2021 Jan 28;11:600005
pubmed: 33633596
Curr Med Res Opin. 2013 Sep;29(9):1093-104
pubmed: 23742051
Atten Defic Hyperact Disord. 2017 Mar;9(1):47-65
pubmed: 27866355
Br J Psychiatry. 2011 Feb;198(2):93-8
pubmed: 21282779
J Forensic Leg Med. 2021 May;80:102180
pubmed: 33991929
Prim Care Companion CNS Disord. 2014;16(3):
pubmed: 25317367
Front Psychiatry. 2018 Aug 02;9:331
pubmed: 30116206
J Atten Disord. 2015 Apr;19(4):328-34
pubmed: 24743975
World Psychiatry. 2020 Jun;19(2):214-232
pubmed: 32394557
Am J Psychiatry. 2008 Jan;165(1):107-15
pubmed: 18006872
J Psychopharmacol. 2011 Nov;25(11):1524-32
pubmed: 20558498
Psychiatry Res. 2019 Mar;273:753-758
pubmed: 31207862
Eur Arch Psychiatry Clin Neurosci. 2009 Mar;259(2):98-105
pubmed: 18806916
Addiction. 2001 Jun;96(6):815-22
pubmed: 11399213
Eur J Psychotraumatol. 2016 Jun 14;7:32061
pubmed: 27306866
Expert Rev Neurother. 2016;16(2):131-44
pubmed: 26693882
J Atten Disord. 2020 Jul;24(9):1246-1254
pubmed: 25882836
Am J Psychiatry. 1994 Aug;151(8):1132-6
pubmed: 8037246
Child Care Health Dev. 2015 Sep;41(5):641-53
pubmed: 25733080
Soc Psychiatry Psychiatr Epidemiol. 2021 Nov;56(11):2083-2093
pubmed: 33751153
Psychiatry Res. 2016 May 30;239:320-4
pubmed: 27058158
Child Adolesc Ment Health. 2021 Nov;26(4):303-309
pubmed: 33939246
BMC Psychiatry. 2018 Jun 25;18(1):210
pubmed: 29940897
Int J Law Psychiatry. 2019 Jan - Feb;62:90-94
pubmed: 30616859
Atten Defic Hyperact Disord. 2014 Jun;6(2):79-86
pubmed: 24610394
Nord J Psychiatry. 2009;63(5):361-7
pubmed: 19247871
Int J Environ Res Public Health. 2012 May;9(5):1908-26
pubmed: 22754481
Curr Drug Abuse Rev. 2012 Sep;5(3):190-8
pubmed: 22571450
Behav Sci Law. 2012 Mar-Apr;30(2):154-66
pubmed: 22496046
Int J Community Based Nurs Midwifery. 2014 Apr;2(2):77-84
pubmed: 25349848

Auteurs

Enrico Capuzzi (E)

Psychiatric Department, Azienda Socio Sanitaria Territoriale Monza, 20900 Monza, Italy.

Martina Capellazzi (M)

Department of Medicine and Surgery, University of Milano Bicocca, 20900 Monza, Italy.

Alice Caldiroli (A)

Psychiatric Department, Azienda Socio Sanitaria Territoriale Monza, 20900 Monza, Italy.

Francesca Cova (F)

Psychiatric Department, Azienda Socio Sanitaria Territoriale Monza, 20900 Monza, Italy.

Anna Maria Auxilia (AM)

Department of Medicine and Surgery, University of Milano Bicocca, 20900 Monza, Italy.

Paola Rubelli (P)

Psychiatric Department, Azienda Socio Sanitaria Territoriale Monza, 20900 Monza, Italy.

Ilaria Tagliabue (I)

Department of Medicine and Surgery, University of Milano Bicocca, 20900 Monza, Italy.

Francesco Giuseppe Zanvit (FG)

Department of Medicine and Surgery, University of Milano Bicocca, 20900 Monza, Italy.

Gianluca Peschi (G)

Department of Social and Health Care, Azienda Socio Sanitaria Territoriale Monza, 20900 Monza, Italy.

Massimiliano Buoli (M)

Department of Neurosciences and Mental Health, Fondazione IRCCS Ca'Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
Department of Pathophysiology and Transplantation, University of Milan, 20122 Milan, Italy.

Massimo Clerici (M)

Psychiatric Department, Azienda Socio Sanitaria Territoriale Monza, 20900 Monza, Italy.
Department of Medicine and Surgery, University of Milano Bicocca, 20900 Monza, Italy.

Classifications MeSH